Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115357) titled 'Intervention of Saccharomyces boulardii on postpartum depression and anxiety and its underlying mechanisms' on Dec. 25, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Tongji Medical College, Huazhong University of Science and Technology

Condition: Postpartum anxiety and depression

Intervention: Experimental group:The participants are required to take Saccharomyces boulardii once daily, with 1 sachet per dose (i.e., 2x10^10 CFU/day), for a total of 12 weeks of intervention. Administration method: Dissolve the intervention in warm water (<50degC) or a sweetened beverage and co...